Related Experiment Video
Updated: Mar 7, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Homodimers of Vanillin and Apocynin Decrease the Metastatic Potential of Human Cancer Cells by Inhibiting the
Phatcharida Jantaree1,2, Kriengsak Lirdprapamongkol2, Wilailak Kaewsri1,2
1Chulabhorn Graduate Institute , Bangkok 10210, Thailand.
Abstract:
The spread of cancer cells to distant organs, in a process called metastasis, is the main factor that contributes to most death in cancer patients. Vanillin, the vanilla flavoring agent, has been shown to suppress metastasis in a mouse model. Here, we evaluated the antimetastatic potential of the food additive divanillin, the homodimer of vanillin, and their structurally related compounds, apocynin and diapocynin, in hepatocellular carcinoma cells. The Transwell invasion assay showed that the dimeric forms exhibited a potency higher than those of vanillin and apocynin in inhibiting invasion, with IC50 values of 23.3 ± 7.4 to 41.3 ± 4.2 μM for the dimers, which are 26-34-fold lower than IC50 values of vanillin and apocynin (p < 0.05). Both monomeric and dimeric forms target regulation of the invasion process by inhibiting phosphorylation of FAK and Akt. Molecular docking studies suggested that the dimers should bind more tightly than vanillin and apocynin to the Y397 pocket of the FAK FERM domain. Thus, the food additive divanillin has antimetastatic potential greater than that of the flavoring agent vanillin.
Insights
The food additive divanillin shows greater potential to inhibit cancer metastasis than vanillin. Both compounds, along with related molecules, target key proteins involved in cancer cell invasion.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Metastasis, the spread of cancer cells, is the primary cause of cancer-related deaths.
- Vanillin, a vanilla flavoring agent, has demonstrated metastasis-suppressing properties in preclinical models.
- Investigating food-derived compounds for anti-cancer properties is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To evaluate the antimetastatic potential of divanillin, a vanillin dimer, and related compounds (apocynin, diapocynin) in hepatocellular carcinoma.
- To compare the efficacy of dimeric compounds against their monomeric counterparts in inhibiting cancer cell invasion.
- To elucidate the molecular mechanisms underlying the antimetastatic effects of these compounds.
Main Methods:
- Transwell invasion assays were performed to quantify cancer cell invasion.
- Inhibition concentrations (IC50) were determined for vanillin, divanillin, apocynin, and diapocynin.
- Western blotting was used to assess the phosphorylation status of focal adhesion kinase (FAK) and Akt.
- Molecular docking studies were conducted to predict binding affinities to FAK.
Main Results:
- Dimeric compounds, including divanillin, were significantly more potent in inhibiting cancer cell invasion than vanillin and apocynin.
- IC50 values for dimers were 26-34 times lower than those for vanillin and apocynin.
- Both monomeric and dimeric compounds inhibited invasion by suppressing FAK and Akt phosphorylation.
- Molecular docking suggested stronger binding of dimers to the FAK FERM domain.
Conclusions:
- The food additive divanillin exhibits superior antimetastatic potential compared to vanillin.
- Divanillin and related dimeric compounds represent promising candidates for further investigation as anti-metastatic agents.
- Targeting FAK and Akt phosphorylation pathways is a key mechanism for the observed antimetastatic effects.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Drugs that Destabilize Microtubules
Inhibition of Cdk Activity
Cancer Cell Migration through Invadopodia
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply